Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years - 70 Years|
- - Develops of self-reported GI symptoms after a single intake of bread or gluten- containing products; - Age between 18-70 years; - Avoiding or restricting gluten-containing foods for at least 1 week before start of as well as during the study (based on a gluten-free dietary compliance questionnaire of Biagi et al.
- - Asymptomatic or only mildly symptomatic (overall) GI symptoms score with VAS < 30mm) while on the gluten-free/gluten-restricted diet; - Must have a freezer (-18ºC) to store the study breads during the study; - Willing and able to give written informed consent and to understand, participate and comply with the research project requirements.
- - Medical history of coeliac disease, wheat allergy, inflammatory bowel disease, presence of an organic gastrointestinal (GI) disease (such as inflammatory bowel disease) or other disease which may interfere with NCGS symptoms (upon judgment of the physician-clinical investigator (Dr.
- - Previous major abdominal surgery or radiotherapy interfering with gastrointestinal function: - Uncomplicated appendectomy, cholecystectomy and hysterectomy allowed unless within the past 6 months; - Other surgery may be allowed based upon judgment of the physician-clinical investigator (Dr.
- - Use of medication potentially influencing gastrointestinal function and/or NCGS symptoms is allowed, provided that dosing has been stable for ≥ 1 month before enrolment; - Use of antibiotics within 90 days prior to the study; - Administration of probiotic, prebiotic supplements, investigational drugs or participation in any scientific intervention study, which may interfere with this study (to be decided by the principle investigator), in the 14 days prior to the study; - Use of immunosuppressive drugs within 90 days before enrolment; - Excessive use of alcohol (>15 alcoholic units per week), or other drugs; - Plan to lose weight or follow a specific weight loss diet within the study period; - Current malignancy; - Pregnancy or breastfeeding; - Participation in any scientific intervention study, which may interfere with this study; - Insufficient fluency of the Dutch language.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Daisy MAE Jonkers, Prof., PhD|
|Principal Investigator Affiliation||Maastricht University|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
The disease, disorder, syndrome, illness, or injury that is being studied.
|Non-Coeliac Gluten Sensitivity (NCGS), Non-Coeliac Wheat Sensitivity (NCWS)|
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.